Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade A 6.26 -0.79% -0.05
HROW closed down 0.79 percent on Friday, May 24, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical HROW trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.79%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.79%
Calm After Storm Range Contraction -0.79%
NR7 Range Contraction -0.79%
Wide Bands Range Expansion -0.79%
Overbought Stochastic Strength -0.79%
1,2,3 Pullback Bullish Bullish Swing Setup -0.32%

Older signals for HROW ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 Citius Pharmaceuticals and Soliton among healthcare gainers; CEL-SCI and BioPharmX among losers
May 13 Harrow Health, Inc. (HROW) CEO Mark Baum on Q1 2019 Results - Earnings Call Transcript
May 10 Harrow: 1Q Earnings Snapshot
May 9 Harrow Health Announces First Quarter 2019 Financial Results
May 7 Harrow Health to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019
May 2 Harrow Health to Announce First Quarter 2019 Financial Results on May 9, 2019
Apr 30 ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
Apr 29 Is Harrow Health's (NASDAQ:HROW) Share Price Gain Of 117% Well Earned?
Mar 15 Harrow Health, Inc. (NASDAQ:HROW) Delivered A Better ROE Than Its Industry
Mar 14 68 Biggest Movers From Yesterday
See more HROW news...
Indicators
Indicator Value
52 Week High 7.2
52 Week Low 1.99
Average Volume 221,912
200-Day Moving Average 4.6732
50-Day Moving Average 5.002
20-Day Moving Average 5.324
10-Day Moving Average 5.994
Average True Range 0.403
ADX 37.08
+DI 31.6654
-DI 7.4828
Chandelier Exit (Long, 3 ATRs ) 5.491
Chandelier Exit (Short, 3 ATRs ) 5.509
Upper Bollinger Band 6.8061
Lower Bollinger Band 3.8419
Percent B (%b) 0.82
BandWidth 55.676183
MACD Line 0.4097
MACD Signal Line 0.2703
MACD Histogram 0.1394
Fundamentals Value
Market Cap 125.6 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -7.73
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.91
Resistance 3 (R3) 6.97 6.81 6.80
Resistance 2 (R2) 6.81 6.64 6.78 6.77
Resistance 1 (R1) 6.53 6.54 6.46 6.48 6.73
Pivot Point 6.38 6.38 6.34 6.35 6.38
Support 1 (S1) 6.10 6.21 6.02 6.04 5.79
Support 2 (S2) 5.94 6.11 5.91 5.75
Support 3 (S3) 5.67 5.94 5.72
Support 4 (S4) 5.61